UNSPSC 51271634: Pyrrocaine hydrochloride

This classification denotes an anesthetic agent with the molecular formula C14H20N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9CST8J378F, chemically known as 1-pyrrolidineaceto-2,6-xylidide but more generally known as pyrrocaine hydrochloride, which bears US NIH Compound Identifier 24361. European Medicines Agency schedules Pyrrocaine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15068MIG.

Most nations, for tariff and trade purposes, schedule pyrrocaine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, PYRROCAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pyrrocaine hydrochloride bears US NLM identifiers UMLS ID C2825619 and NCI Concept Code C81405. SMILES: CC1CCCC(C1NC(=O)CN2CCCC2)C.CL.

UNSPSC 51271634 Pyrrocaine hydrochloride is a Commodity code for a local anesthetic pharmaceutical used in state and local procurement, though the source provides no recent contract opportunities under this code. State and local governments procure pyrrocaine hydrochloride — a topical anesthetic compound — primarily through established pharmaceutical supply chains and standing state health department or corrections department contracts rather than through discrete solicitations posted to public notice boards. The issuing bodies that would acquire this substance include state departments of health, corrections, and human services; county health departments; municipal emergency medical services; and institutional healthcare facilities within school districts and transit authorities, though the sparse recent-activity record suggests procurement is managed through framework agreements or blanket ordering rather than individual RFPs, RFQs, or ITBs.

No recent state or local contract opportunities appear in the available dataset for pyrrocaine hydrochloride, indicating either that procurement occurs through standing orders, cooperative purchasing vehicles, or direct purchases below the public-notice threshold, or that the pharmaceutical is not currently in active demand across state and local jurisdictions at the solicitation level. Business development professionals evaluating this code should verify current demand directly with state pharmacy benefit managers, corrections procurement offices, and emergency medical services administrators rather than relying on posted notice activity.